BOOK
Adult Brain Tumors, An Issue of Neuroimaging Clinics of North America, E-Book
(2016)
Additional Information
Book Details
Abstract
This issue of Neuroimaging Clinics of North America focuses on Adult Brain Tumors, and is edited by Dr. Lara Brandão. Articles will include: Posterior Fossa Tumors in Adult Patients; Lymphomas and Adult Brain Tumors; Pre-Treatment Evaluation of Gliomas; Post Treatment Evaluation of Gliomas; Metastasis in Adult Brain Tumors; Extraparenchymal Lesions in Adult Brain Tumors; Interesting Case Studies in Adult Brain Tumors; Advanced MR Imaging Techniques in Daily Practice; and more!
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Adult Brain Tumors | i | ||
| Copyright\r | ii | ||
| CME Accreditation Page | iii | ||
| PROGRAM OBJECTIVE | iii | ||
| TARGET AUDIENCE | iii | ||
| LEARNING OBJECTIVES | iii | ||
| ACCREDITATION | iii | ||
| DISCLOSURE OF CONFLICTS OF INTEREST | iii | ||
| UNAPPROVED/OFF-LABEL USE DISCLOSURE | iii | ||
| TO ENROLL | iii | ||
| METHOD OF PARTICIPATION\r | iii | ||
| CME INQUIRIES/SPECIAL NEEDS | iii | ||
| NEUROIMAGING CLINICS OF NORTH AMERICA\r | iv | ||
| FORTHCOMING ISSUES | iv | ||
| February 2017 | iv | ||
| May 2017 | iv | ||
| August 2017 | iv | ||
| RECENT ISSUES | iv | ||
| August 2016 | iv | ||
| May 2016 | iv | ||
| February 2016 | iv | ||
| Contributors | v | ||
| CONSULTING EDITOR | v | ||
| EDITOR | v | ||
| AUTHORS | v | ||
| Contents | vii | ||
| Foreword: Adult Brain Tumors\r | vii | ||
| Preface: Adult Brain Tumors: Imaging Characterization of Primary, Secondary, and Extraparenchymal Tumors in the Central Ner ...\r | vii | ||
| Posterior Fossa Tumors in Adult Patients\r | vii | ||
| Lymphomas–Part 1\r | vii | ||
| Lymphomas–Part 2\r | vii | ||
| Pretreatment Evaluation of Glioma\r | viii | ||
| Posttreatment Evaluation of Brain Gliomas\r | viii | ||
| Metastasis in Adult Brain Tumors\r | viii | ||
| Extraparenchymal Lesions in Adults\r | viii | ||
| Advanced MR Imaging Techniques in Daily Practice\r | viii | ||
| Adult Brain Tumors and Pseudotumors: Interesting (Bizarre) Cases\r | ix | ||
| Foreword:\rAdult Brain Tumors | xi | ||
| Preface:\rAdult Brain Tumors | xiii | ||
| Posterior Fossa Tumors in Adult Patients | 493 | ||
| Key points | 493 | ||
| OVERVIEW OF THE POSTERIOR FOSSA | 493 | ||
| MENINGEAL TUMORS: HEMANGIOBLASTOMA (WHO GRADE I) | 495 | ||
| EMBRYONAL TUMORS: MEDULLOBLASTOMA (WHO GRADE IV) | 495 | ||
| ASTROCYTIC TUMORS: PILOCYTIC ASTROCYTOMA (WHO GRADE I) | 496 | ||
| ASTROCYTIC/OLIGODENDROGLIAL TUMORS: DIFFUSE/INFILTRATIVE GLIOMAS (WHO GRADES II–IV) | 499 | ||
| EPENDYMAL TUMORS: SUBEPENDYMOMA AND EPENDYMOMA (WHO GRADES I–III) | 501 | ||
| CHOROID PLEXUS TUMORS AND MENINGIOMA (WHO GRADES I–III) | 501 | ||
| NEURONAL TUMORS: DYSPLASTIC CEREBELLAR GANGLIOCYTOMA (WHO GRADE I) | 504 | ||
| NEURONAL TUMORS: CEREBELLAR LIPONEUROCYTOMA (WHO GRADE II) | 506 | ||
| NEURONAL TUMORS: ROSETTE-FORMING GLIONEURONAL TUMOR OF THE FOURTH VENTRICLE (WHO GRADE I) | 506 | ||
| REFERENCES | 508 | ||
| Lymphomas–Part 1 | 511 | ||
| Key points | 511 | ||
| INTRODUCTION | 511 | ||
| IMAGING FINDINGS | 512 | ||
| Location | 512 | ||
| Computed Tomography and Conventional MR Imaging | 514 | ||
| Necrosis and Hemorrhage | 514 | ||
| Calcification | 515 | ||
| Edema | 515 | ||
| Contrast Enhancement | 515 | ||
| IMAGING CHARACTERISTICS ON ADVANCED MR IMAGING | 516 | ||
| Diffusion-Weighted Imaging | 516 | ||
| Diagnostic value | 516 | ||
| Prognostic biomarker | 519 | ||
| Diffusion Tensor Imaging | 519 | ||
| Proton MR Spectroscopy | 520 | ||
| Dynamic Susceptibility Contrast and Dynamic Contrast-Enhanced MR Imaging | 521 | ||
| Diagnostic value | 521 | ||
| Prognostic biomarker | 521 | ||
| POSTTREATMENT CHANGES (RELATED TO STEROIDS) | 522 | ||
| Steroid Therapy, Take Home Messages | 530 | ||
| SUMMARY | 534 | ||
| REFERENCES | 534 | ||
| Lymphomas–Part 2 | 537 | ||
| Key points | 537 | ||
| SPECIAL LYMPHOMA TYPES | 537 | ||
| Lymphomatosis Cerebri | 537 | ||
| Pearls | 537 | ||
| Intravascular Lymphoma | 537 | ||
| Epidemiology and risk factors | 539 | ||
| Clinical features | 540 | ||
| Laboratory findings | 540 | ||
| Imaging findings | 540 | ||
| Infarct-like lesions | 542 | ||
| Nonspecific white matter lesions | 542 | ||
| Masslike lesions | 542 | ||
| Meningeal enhancement | 542 | ||
| Hyperintense T2 lesions in the pons | 542 | ||
| Lymphomatoid Granulomatosis | 544 | ||
| Clinical picture | 545 | ||
| Imaging findings | 545 | ||
| DIFFERENTIAL DIAGNOSIS | 545 | ||
| Focal and Multifocal Brain Lesions | 545 | ||
| Glioblastoma | 545 | ||
| Multifocal glioma | 546 | ||
| Multiple sclerosis | 546 | ||
| Contrast enhancement | 547 | ||
| Diffusion-weighted imaging/apparent diffusion coefficient | 547 | ||
| Perfusion and permeability | 547 | ||
| Tumefactive demyelinating lesions | 547 | ||
| Toxoplasmosis | 552 | ||
| Diffusion-weighted imaging/apparent diffusion coefficient | 552 | ||
| Magnetic resonance spectroscopy | 553 | ||
| Perfusion and permeability | 553 | ||
| Infiltrative Diffuse Lesion with No Discernible Mass | 553 | ||
| Lymphomatois cerebri versus gliomatosis cerebri | 553 | ||
| Lymphomatosis cerebri versus microangiopathy (Binswanger disease) | 553 | ||
| Lymphomatosis cerebri versus progressive multifocal leukoencephalopathy | 555 | ||
| Intravascular Lymphoma | 555 | ||
| Intravascular lymphoma versus embolic infarcts | 555 | ||
| Intravascular lymphoma versus vasculitis | 557 | ||
| Ependymal Enhancement | 557 | ||
| Meningeal Enhancement | 560 | ||
| SUMMARY | 561 | ||
| REFERENCES | 562 | ||
| Pretreatment Evaluation of Glioma | 567 | ||
| Key points | 567 | ||
| INTRODUCTION | 567 | ||
| CONVENTIONAL IMAGING TECHNIQUES | 568 | ||
| MODERN IMAGING TECHNIQUES | 569 | ||
| Magnetic Resonance Perfusion Imaging | 569 | ||
| Diffusion-weighted Imaging | 570 | ||
| Susceptibility-weighted Imaging | 571 | ||
| Magnetic Resonance Spectroscopy | 571 | ||
| Functional MR imaging | 573 | ||
| Diffusion Tensor Imaging | 575 | ||
| PET | 575 | ||
| Glucose Metabolism | 575 | ||
| Amino Acid Transport and Protein Synthesis | 575 | ||
| Proliferation Rate | 576 | ||
| Membrane Biosynthesis | 576 | ||
| Oxygen Metabolism | 576 | ||
| Perfusion | 576 | ||
| Biopsy Targeting | 576 | ||
| Radiation Therapy Planning with PET | 576 | ||
| PET/Magnetic Resonance | 576 | ||
| SUMMARY | 576 | ||
| REFERENCES | 577 | ||
| Posttreatment Evaluation of Brain Gliomas | 581 | ||
| Key points | 581 | ||
| INTRODUCTION | 581 | ||
| TUMOR BIOLOGY | 582 | ||
| IMAGING TIME FRAME | 582 | ||
| CHALLENGES WITH IMAGING | 582 | ||
| Mimics of Progression (Increased Enhancement) | 583 | ||
| Subacute infarction and postoperative blood–brain barrier disruption | 583 | ||
| Pseudoprogression | 583 | ||
| Delayed radiation necrosis | 583 | ||
| Mimics of Improvement (Decreased Enhancement) | 583 | ||
| Pseudoresponse | 583 | ||
| RADIOLOGIC INTERPRETATIONS BASED ON ROUTINE PULSE SEQUENCES | 584 | ||
| Response Assessment in Neuro-Oncology Criteria | 584 | ||
| Clinical data to gather before beginning interpretation | 585 | ||
| Enhancement | 586 | ||
| T2/Fluid Attenuation Inversion Recovery Imaging | 587 | ||
| Diffusion Signal | 589 | ||
| ADVANCED MR IMAGING TECHNIQUES | 589 | ||
| Dynamic Susceptibility Contrast-Enhanced Perfusion | 589 | ||
| Dynamic Contrast-Enhanced Perfusion | 590 | ||
| Arterial Spin Labeling Perfusion | 590 | ||
| Choosing a Perfusion Technique | 590 | ||
| Diffusion Tensor Imaging | 590 | ||
| Spectroscopy | 590 | ||
| NUCLEAR MEDICINE TECHNIQUES | 593 | ||
| 18Fludeoxyglucose PET | 593 | ||
| Other PET Agents | 594 | ||
| WHAT THE REFERRING CLINICIAN NEEDS TO KNOW | 595 | ||
| SUMMARY | 595 | ||
| REFERENCES | 596 | ||
| Metastasis in Adult Brain Tumors | 601 | ||
| Key points | 601 | ||
| INTRODUCTION | 601 | ||
| NORMAL ANATOMY AND IMAGING TECHNIQUES | 602 | ||
| Anatomy of the Cranial Meninges | 602 | ||
| Preferential Locations of Central Nervous System Metastasis | 603 | ||
| Neuroimaging Approach and Techniques | 604 | ||
| Initial Diagnosis | 604 | ||
| Preoperative and Therapy Planning | 607 | ||
| Post-Treatment Evaluation | 607 | ||
| IMAGING FINDINGS AND PATHOLOGY | 610 | ||
| Skull Metastases | 610 | ||
| Pachymeningeal Carcinomatosis | 610 | ||
| Leptomeningeal Carcinomatosis | 613 | ||
| Parenchymal Metastases | 613 | ||
| Differentiating Progression of Disease from Effects of Stereotactic Radiation Therapy | 618 | ||
| Distinguishing Solitary Metastasis from High-Grade Glioma | 618 | ||
| Pearls, Pitfalls, and Variants | 619 | ||
| Non-neoplastic hematomas | 619 | ||
| Remote microvascular ischemia | 619 | ||
| Ischemic infarction | 619 | ||
| SUMMARY | 620 | ||
| REFERENCES | 620 | ||
| Extraparenchymal Lesions in Adults | 621 | ||
| Key points | 621 | ||
| MENINGIOMA | 621 | ||
| HEMANGIOPERICYTOMA | 626 | ||
| NEUROSARCOIDOSIS | 628 | ||
| LANGERHANS CELL HISTIOCYTOSIS | 630 | ||
| ROSAI-DORFMAN DISEASE | 630 | ||
| PITUITARY MASSES | 632 | ||
| EPIDERMOID AND DERMOID | 634 | ||
| ARACHNOID CYSTS | 636 | ||
| COLLOID CYSTS | 637 | ||
| PINEAL REGION TUMORS | 639 | ||
| SUMMARY | 644 | ||
| REFERENCES | 645 | ||
| Advanced MR Imaging Techniques in Daily Practice | 647 | ||
| Key points | 647 | ||
| INTRODUCTION | 647 | ||
| NORMAL ANATOMY AND IMAGING TECHNIQUE | 648 | ||
| Diffusion-weighted Imaging and Related Techniques (Tagging: Diffusion-weighted Imaging, Diffusion-tensor Imaging) | 648 | ||
| T2* Susceptibility-sensitive Sequences (Tagging: Susceptibility-weighted Imaging, T2*, Susceptibility, Microhemorrhage) | 649 | ||
| Magnetic Resonance Spectroscopy (Tagging: Magnetic Resonance Spectroscopy) | 651 | ||
| Perfusion Imaging (Tagging: Perfusion, Dynamic Susceptibility Contrast Enhanced, Dynamic Contrast Enhanced, Arterial Spin L ... | 655 | ||
| Functional MR Imaging (Tagging: Blood Oxygen Level Dependent, Functional MR Imaging, Resting-state Functional MR Imaging) | 658 | ||
| IMAGING FINDINGS/PATHOLOGY | 658 | ||
| Diffusion-weighted Imaging and Related Techniques (Tagging: Diffusion-weighted Imaging, Diffusion-tensor Imaging) | 658 | ||
| T2* Susceptibility–sensitive Sequences (Tagging: Susceptibility-weighted Imaging, SWAN, T2*, Susceptibility, Microhemorrhage) | 660 | ||
| Magnetic Resonance Spectroscopy (Tagging: Magnetic Resonance Spectroscopy) | 660 | ||
| Perfusion Imaging (Tagging: Perfusion, Dynamic Susceptibility Contrast Enhanced, Dynamic Contrast Enhanced, Arterial Spin L ... | 660 | ||
| Functional MR Imaging (Tagging- Blood Oxygen Level–Dependent, Functional MR Imaging, Resting-state Functional MR Imaging) | 661 | ||
| SUMMARY | 663 | ||
| REFERENCES | 663 | ||
| Adult Brain Tumors and Pseudotumors | 667 | ||
| Key points | 667 | ||
| INTRODUCTION | 667 | ||
| PINEAL CHORIOCARCINOMA | 667 | ||
| Epidemiology | 668 | ||
| Location | 668 | ||
| Clinical Presentation | 668 | ||
| Imaging Findings | 668 | ||
| Histopathology | 668 | ||
| Treatment | 669 | ||
| Differential Diagnosis | 669 | ||
| Prognosis | 669 | ||
| EXTRAVENTRICULAR NEUROCYTOMA | 669 | ||
| Epidemiology | 669 | ||
| Location | 669 | ||
| Clinical Presentation | 669 | ||
| Imaging Findings | 669 | ||
| Histopathology | 669 | ||
| Treatment | 670 | ||
| Index | 691 |